Skip to main content
. Author manuscript; available in PMC: 2022 Nov 22.
Published in final edited form as: J Alzheimers Dis. 2019;72(4):1077–1087. doi: 10.3233/JAD-190643

TABLE 4.

Regression analysis of the relationship between APOE ε4/ε4 genotype and presence of AMB with comorbid neuropathological substrates in HAD

Predictors Odds Ratio
(95% CI)
P value
HAD females
No ε4 & ε4 (indicator)
ε4/ε4 1.923
(1.175-3.149)
0.009
HAD males
No ε4 & ε4 (indicator)
ε4/ε4 1.653
(1.108-2.465)
0.014
HAD with LB
No ε4 & ε4 (indicator)
ε4/ε4 2.390
(1.535-3.722)
0.001
HAD with LB, females
No ε4 & ε4 (indicator)
ε4/ε4 2.870
(1.412-5.834)
0.004
HAD with LB, males
No ε4 & ε4 (indicator)
ε4/ε4 2.136
(1.208-3.775)
0.009
HAD without LB
No ε4 & ε4 (indicator)
ε4/ε4 1.269
(0.810-1.987)
0.298
HAD without LB, females
No ε4 & ε4 (indicator)
ε4/ε4 1.405
(0.692-2.852)
0.347
HAD without LB, males
No ε4 & ε4 (indicator)
ε4/ε4 1.225
(0.683-2.197)
0.497
HAD with CAA
No ε4 & ε4 (indicator)
ε4/ε4 1.826
(1.306-2.552)
0.001
HAD with CAA, females
No ε4 & ε4 (indicator)
ε4/ε4 1.835
(1.075-3.131)
0.026
No ε4 & ε4 (indicator)
ε4/ε4 1.809
(1.176-2.781)
0.007
HAD without CAA
No ε4 & ε4 (indicator)
ε4/ε4 1.129
(0.417-3.052)
0.811
HAD without CAA, females
No ε4 & ε4 (indicator)
ε4/ε4 3.300
(0.633-17.211)
0.157
HAD without CAA, males
No ε4 & ε4 (indicator)
ε4/ε4 0.585
(0.155-2.212)
0.430

Table representing LB and CAA’s impact as separate comorbid neuropathological substrates on the relationship between APOE4 and AMB in HAD. Predictors referred to presence of two (ε4/ε4) copies of the ε4 allele of the APOE gene in HAD cases with or without Lewy Bodies (LB), as well as with or without Cerebral Amyloid Angiopathy (CCA). Numerical values within each column represent Odds Ratio (OR) with associated 95% Confidence Interval (95% CI) and p value. The relationship between APOE4 genotype and AMB prevalence was assessed in an unadjusted logistic regression model.